L1CAMxCD3 bispecific antibodies exert potent anti-tumor effects in preclinical pancreatic cancer models considering the complex tumor stroma
A. Wandmacher
A. Brauer
Charlotte Kayser
Caj Stach
Jakob Werner
Silje Beckinger
T. Daunke
Leon Baumann
B. Heckelmann
A. Hidam
O. Lapshyna
D. Wesch
A. Mehdorn
C. Röcken
R. Braun
Flavio Mehli
Anne Schmidt
Gunther Spohn
S. Sebens
Biology